Table: Hisamitsu -2021/22 parent results
Apr 7 (Reuters)-
Hisamitsu Pharmaceutical Co Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Feb 28, 2022 Feb 28, 2021 Feb 28, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 90.59 86.69
(+4.5 pct) (-21.0 pct)
Operating 8.62 9.44
(-8.7 pct) (-53.5 pct)
Recurring 10.61 10.37
(+2.3 pct) (-51.8 pct)
Net 7.17 8.34
(-14.1 pct) (-44.7 pct)
EPS 88.25 yen 102.07 yen
EPS Diluted 88.19 yen 101.97 yen
Ann Div 84.00 yen 83.50 yen 84.50 yen
-Q2 Div 42.00 yen 41.75 yen 42.25 yen
-Q4 Div 42.00 yen 41.75 yen 42.25 yen
NOTE - Hisamitsu Pharmaceutical Co Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4530.T
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO